RVXOldtimer ... great post, as always. I was tthinking along the same lines with Hepalink, you said it better. Depending on how BIG and bright the future looks for RVX with apabetalone for Cardio, Renal, Cognitive, PH, Fabry's, etc., PLUS 2-3000 other molecules, and all the finance and operations it would take to maximize those potential opportunities ... I have been locked into a BP in my mind. Big multi-national, with multiple manufacturing sites, distribution networks around the world, etc. Keep in mind, in the U.S. at least, a BP will likely have a competely different sales force calling on Cardio, Renal, Cognitive, etc ... highly specialized areas with multiple therapies. Although a specialty sales force dealing with a single product could probably call on multi-specialty and learn the ins & outs of the unique specialties related to their drug though, since they may not be carrying multiple drugs unless RVX sells to or licenses to an existing BP and drops apabetalone into the existing sales force "bag" and utilizes those relationships and distribution channels.

But I could see Hepalink dealing with Asia, and another groupd dealing with other parts of the world.

If Hepalink and RVX decided to "give it a go" together without BP's, then maybe Hepalinks finance partners (Orion?) and manufacturing would work well with RVX's foothold in N.America, they would need to either license with a BP or develop a sales force from scratch or building upon whatever existing distribution Hepalink has in N.America and around the world?

I wonder if RVX has even begun to design/work on packaging and labeling (pending approvals for language of course) haha ... ohhhh the little stuff :)